Concepedia
Statistics
Publications
11
Citations
387
H-Index
10
Active since
1996
Affiliations
Capital Health(Current)
Thomson Reuters (United States)
Indiana University – Purdue University Indianapolis
Raf Magar is an author at Capital Health specializing in medicine, botulinum toxin therapy, and neurology.
Publications per year
1996–2016
Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study
Albert Marchetti, Raf Magar, Leslie J. Findley et al. · Movement Disorders · 2005 · 111 citations
Medicine, Neurology, Pharmacotherapy +14
Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: Potential for savings
Albert Marchetti, Helen Lau, Raf Magar et al. · Clinical Therapeutics · 1999 · 56 citations
Medicine, Infectious Diseases, Pediatrics +14
Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review
Allison Brashear, Maureen Wooten Watts, Albert Marchetti et al. · Clinical Therapeutics · 2000 · 46 citations
Medicine, Neurology, Neuroscience +8
A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx®) versus intravenous phenytoin (Dilantin®) in hospital emergency departments
Albert Marchetti, Raf Magar, James H. Fischer et al. · Clinical Therapeutics · 1996 · 42 citations
Pharmacy, Pharmacoeconomics, Pharmacology +13
Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis
Albert Marchetti, Raf Magar, Helen Lau et al. · Clinical Therapeutics · 2001 · 40 citations
Pharmacy, Pharmacoeconomics, Pharmacotherapy +12
1–5 of 11